Rhumbline Advisers Health Catalyst, Inc. Transaction History

Rhumbline Advisers

$104 Billion
Q1 2025

A detailed history of Rhumbline Advisers transactions in Health Catalyst, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 89,859 shares of HCAT stock, worth $368,421. This represents 0.0% of its overall portfolio holdings.

Number of Shares

89,859

Previous 90,441 0.64%

Holding current value

$368,421

Previous $639,000 36.15%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 08, 2025	SELL	$3.97 - $7.42 $2,310 - $4,318	-582 Reduced 0.64%	89,859 $408,000
Q4 2024 Jan 30, 2025	BUY	$6.9 - $9.02 $7,189 - $9,398	1,042 Added 1.17%	90,441 $639,000
Q3 2024 Nov 12, 2024	SELL	$5.48 - $8.83 $9,381 - $15,116	-1,712 Reduced 1.88%	89,399 $727,000
Q2 2024 Aug 01, 2024	BUY	$5.53 - $7.28 $41,967 - $55,247	7,589 Added 9.09%	91,111 $582,000
Q1 2024 May 09, 2024	BUY	$7.44 - $11.21 $12,223 - $18,418	1,643 Added 2.01%	83,522 $628,000
Q4 2023 Feb 08, 2024	BUY	$6.71 - $10.16 $154 - $233	23 Added 0.03%	81,879 $758,000
Q3 2023 Nov 09, 2023	BUY	$9.35 - $14.32 $36,137 - $55,346	3,865 Added 4.96%	81,856 $828,000
Q2 2023 Aug 08, 2023	SELL	$9.86 - $13.12 $94,833 - $126,188	-9,618 Reduced 10.98%	77,991 $974,000
Q1 2023 May 11, 2023	SELL	$10.23 - $14.76 $135,680 - $195,761	-13,263 Reduced 13.15%	87,609 $1.02 Million
Q4 2022 Feb 14, 2023	BUY	$6.86 - $11.32 $128,144 - $211,457	18,680 Added 22.73%	100,872 $1.07 Million
Q3 2022 Nov 10, 2022	BUY	$9.3 - $18.27 $49,569 - $97,379	5,330 Added 6.93%	82,192 $797,000
Q2 2022 Aug 11, 2022	BUY	$11.79 - $27.63 $279,104 - $654,084	23,673 Added 44.51%	76,862 $1.11 Million
Q1 2022 May 12, 2022	BUY	$20.67 - $40.33 $84,622 - $165,111	4,094 Added 8.34%	53,189 $1.39 Million
Q4 2021 Feb 10, 2022	BUY	$36.68 - $54.02 $15,002 - $22,094	409 Added 0.84%	49,095 $1.95 Million
Q3 2021 Nov 12, 2021	BUY	$49.57 - $58.15 $251,319 - $294,820	5,070 Added 11.62%	48,686 $2.44 Million
Q2 2021 Aug 05, 2021	BUY	$47.17 - $58.64 $336,463 - $418,279	7,133 Added 19.55%	43,616 $2.42 Million
Q1 2021 May 06, 2021	SELL	$42.51 - $54.07 $163,110 - $207,466	-3,837 Reduced 9.52%	36,483 $1.71 Million
Q4 2020 Feb 10, 2021	BUY	$31.9 - $44.89 $31,325 - $44,081	982 Added 2.5%	40,320 $1.76 Million
Q3 2020 Nov 12, 2020	SELL	$28.55 - $36.91 $145,890 - $188,610	-5,110 Reduced 11.5%	39,338 $1.44 Million
Q2 2020 Aug 13, 2020	BUY	$24.0 - $32.87 $514,152 - $704,174	21,423 Added 93.04%	44,448 $1.3 Million
Q1 2020 May 06, 2020	BUY	$17.8 - $37.6 $274,440 - $579,716	15,418 Added 202.68%	23,025 $602,000
Q4 2019 Feb 05, 2020	BUY	$26.44 - $40.63 $6,900 - $10,604	261 Added 3.55%	7,607 $264,000
Q3 2019 Oct 23, 2019	BUY	$30.31 - $48.63 $222,657 - $357,235	7,346 New	7,346 $232,000

Others Institutions Holding HCAT

# of Institutions

174

Shares Held

50.6M

Call Options Held

2.97M

Put Options Held

16.1K

View Full List

About Health Catalyst, Inc.

Ticker HCAT
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 54,723,400
Market Cap $224M
Description
Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its offerings include data and analytics platform, a commercial-grade data and analytics platform for the healthcare sector; AI and data science, providing integration of AI into existing business intelligence tools, increasing analytics accura...

More about HCAT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account

Rhumbline Advisers Health Catalyst, Inc. Transaction History